z-logo
open-access-imgOpen Access
Brentuximab vedotin maintenance after autologous stem cell transplantation for refractory gray zone lymphoma with long‑term remission
Author(s) -
Toshiki Terao,
Junichiro Yuda,
Nobuhiko Yamauchi,
YongMei Guo,
Kaoru Shimada,
Masato Sugano,
Genichiro Ishii,
Yosuke Minami
Publication year - 2021
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2021.2287
Subject(s) - brentuximab vedotin , autologous stem cell transplantation , medicine , lymphoma , oncology , cd30 , transplantation , stem cell , biology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here